Distinguished Professor of Epidemiology;
Associate Dean for Research,
School of Public Health and Health Sciences
University of Massachusetts
In recognition of fundamental research that has led to the development of chemopreventive drugs (e.g., Tamoxifen) for breast cancer patients and an improved understanding as to how lifestyle alterations (e.g., reducing adiposity, increasing physical activity, decreasing alcohol consumption) can reduce breast cancer risk.
To learn more, please visit the press release.